BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Dow Pharmaceutical Sciences 

1330A Redwood Way

Petaluma  California  94954  U.S.A.
Phone: 707-793-2600 Fax: 707-793-0145


SEARCH JOBS








 Company News
Dow Pharmaceutical Sciences Becomes Wholly Owned Subsidiary as Acquisition by Valeant Pharmaceuticals International (VRX) is Completed 1/9/2009 11:51:56 AM    More...
Valeant Pharmaceuticals International (VRX) Completes Acquisition of Dow Pharmaceutical Sciences 1/2/2009 10:53:04 AM    More...
Valeant Pharmaceuticals International (VRX) to Acquire Dow Pharmaceutical Sciences for $285 Million 12/10/2008 6:29:04 AM    More...
Dow Pharmaceutical Sciences to Present Scientific Poster at American Association of Pharmaceutical Scientists Evaluating the Affect of Flow Rate, Tissue Thickness and Receptor Phase Type on Drug Penetration When Appied Topically to Human Dermatomed and Dermis Only Skin 10/30/2008 11:08:19 AM    More...
Dow Pharmaceutical Sciences Expands Clinical Labeling Capabilities in Petaluma, California 9/4/2008 8:25:29 AM    More...
Kaken Pharmaceuticals To License Its Antifungal Compound KP-103 To Dow Pharmaceutical Sciences 5/11/2006 3:18:58 PM    More...
DOR BioPharma, Inc. (DOR) And Dow Pharmaceutical Sciences Complete Feasibility Study For Production Of BT-VACC 11/17/2005 11:51:42 AM    More...
FDA Receives Dow Pharmaceutical Sciences Approval Of NDA For Galderma's Clobex(R) Spray For Moderate-To-Severe Plaque Psoriasis 11/2/2005 11:00:57 AM    More...
Dr. Daniel Bucks, Director Of The Skin Biology And Drug Delivery Laboratory At Dow Pharmaceutical Sciences, Speaks On Skin Permeation Enhancement Techniques At AAPS Convention In Baltimore 10/19/2005 5:12:23 PM    More...
Dow Pharmaceutical Sciences Appoints Sandra Calman, MD As Director Of Clinical Research For The Solano Clinical Research Unit 10/19/2005 5:12:15 PM    More...
12

//-->